[The treatment of gastric carcinoma in III stage].
From 1975 to 1989, we treated 238 cases of gastric carcinoma in III stage, 90.7% of these were followed up. The total 5-year survival rate was 45.4%, 10-year survival 33.7%. The 5-year survival rate and 10-year survival rate (56.3% and 47.5%) in the extensive radical treatment group (102 cases, selective R3 or R3) was much higher than that of routine radical treatment group (114 cases R2). The 5-year survival rate and 10-year survival rate in the group with auxillary post-operational chemotherapy were much higher than those of the group without chemotherapy. The post-operative survival rate in the group with chemotherapy plus Chinese medicine was much higher than that of the group with chemotherapy alone. The peritoneal metastatic rate of the group with peritoneal flushing plus chemotherapy (18.7% and 20.6%) was much longer than that of the group without peritoneal flushing and/or chemotherapy (31.9%). We consider that the best treatment of gastric carcinoma in III stage is the sufficient removal of gastric lymph nodes for the prevention of metastasis through peritoneal and circulatory route.
Lin
C
C
Shanghai Sixth People's Hospital.
Zhu
X
X
Chai
Z
Z
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy / Q000401:mortality; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D015996:Survival Rate
D004365:Drugs, Chinese Herbal